MX2019006821A - Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos. - Google Patents
Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos.Info
- Publication number
- MX2019006821A MX2019006821A MX2019006821A MX2019006821A MX2019006821A MX 2019006821 A MX2019006821 A MX 2019006821A MX 2019006821 A MX2019006821 A MX 2019006821A MX 2019006821 A MX2019006821 A MX 2019006821A MX 2019006821 A MX2019006821 A MX 2019006821A
- Authority
- MX
- Mexico
- Prior art keywords
- gastrointestinal tract
- disease
- treatment
- devices
- jak inhibitor
- Prior art date
Links
- 229940122245 Janus kinase inhibitor Drugs 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00002—Operational features of endoscopes
- A61B1/00004—Operational features of endoscopes characterised by electronic signal processing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00002—Operational features of endoscopes
- A61B1/00004—Operational features of endoscopes characterised by electronic signal processing
- A61B1/00009—Operational features of endoscopes characterised by electronic signal processing of image signals during a use of endoscope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00064—Constructional details of the endoscope body
- A61B1/00071—Insertion part of the endoscope body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00064—Constructional details of the endoscope body
- A61B1/00071—Insertion part of the endoscope body
- A61B1/0008—Insertion part of the endoscope body characterised by distal tip features
- A61B1/00097—Sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00131—Accessories for endoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/012—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/012—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
- A61B1/015—Control of fluid supply or evacuation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/041—Capsule endoscopes for imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/045—Control thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
- A61B1/2736—Gastroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0097—Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/1053—Stomach
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/1053—Stomach
- A61M2210/1057—Duodenum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/106—Small intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5412—IL-6
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/55—IL-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Signal Processing (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
Abstract
Esta descripción presenta métodos y composiciones para tratar enfermedades del tracto gastrointestinal con un inhibidor de JAK.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662434374P | 2016-12-14 | 2016-12-14 | |
US201762478919P | 2017-03-30 | 2017-03-30 | |
US201762545380P | 2017-08-14 | 2017-08-14 | |
US201762583832P | 2017-11-09 | 2017-11-09 | |
PCT/US2017/066492 WO2018112245A1 (en) | 2016-12-14 | 2017-12-14 | Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019006821A true MX2019006821A (es) | 2019-10-21 |
Family
ID=60953958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019006821A MX2019006821A (es) | 2016-12-14 | 2017-12-14 | Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos. |
Country Status (10)
Country | Link |
---|---|
US (2) | US11033490B2 (es) |
EP (2) | EP3554485B9 (es) |
JP (2) | JP2020502126A (es) |
KR (1) | KR20190097107A (es) |
CN (2) | CN116869457A (es) |
AU (2) | AU2017378398B2 (es) |
BR (1) | BR112019012062A2 (es) |
CA (1) | CA3045666A1 (es) |
MX (1) | MX2019006821A (es) |
WO (1) | WO2018112245A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201840318A (zh) * | 2017-03-09 | 2018-11-16 | 美商艾伯維有限公司 | 治療克羅恩氏病和潰瘍性結腸炎之方法 |
US11564922B2 (en) | 2017-03-09 | 2023-01-31 | Abbvie Inc. | Methods of treating crohn's disease and ulcerative colitis |
US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
AU2018269556B2 (en) | 2017-05-17 | 2024-01-25 | Massachusetts Institute Of Technology | Tissue anchoring articles |
CA3100710A1 (en) | 2018-05-17 | 2019-11-21 | Massachusetts Institute Of Technology | Systems for electrical stimulation |
US20220257600A1 (en) * | 2018-06-20 | 2022-08-18 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor |
US11771829B2 (en) | 2019-02-01 | 2023-10-03 | Massachusetts Institute Of Technology | Systems and methods for liquid injection |
CN112393827A (zh) * | 2019-08-12 | 2021-02-23 | 南京理工大学 | 一种可生物降解的压电力传感器的制备方法 |
CN112578123B (zh) * | 2019-09-27 | 2022-10-25 | 成都中医药大学 | 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途 |
US11541216B2 (en) | 2019-11-21 | 2023-01-03 | Massachusetts Institute Of Technology | Methods for manufacturing tissue interfacing components |
WO2021174024A1 (en) | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
CN115867272A (zh) * | 2020-05-14 | 2023-03-28 | 施万生物制药研发Ip有限责任公司 | 肠道选择性jak3抑制剂的给药 |
CN111920812B (zh) * | 2020-07-10 | 2022-09-20 | 深圳市臻质医疗科技有限公司 | 一种钙通道抑制剂氧海罂粟碱在骨关节炎中的应用 |
CN113081075B (zh) * | 2021-03-09 | 2022-03-04 | 武汉大学 | 一种具有主动式活检与施药功能的磁控胶囊 |
KR20230162959A (ko) * | 2021-03-31 | 2023-11-29 | 쿨리아 랩스, 인크. | 휴대용 초분광 시스템 |
Family Cites Families (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
IL47062A (en) | 1975-04-10 | 1979-07-25 | Yeda Res & Dev | Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde |
US4281645A (en) | 1977-06-28 | 1981-08-04 | Duke University, Inc. | Method and apparatus for monitoring metabolism in body organs |
US4190328A (en) | 1978-12-01 | 1980-02-26 | Levine Robert A | Process for detection of blood-borne parasites |
JPS5588732A (en) | 1978-12-26 | 1980-07-04 | Olympus Optical Co | Endoscope |
US4665077A (en) | 1979-03-19 | 1987-05-12 | The Upjohn Company | Method for treating rejection of organ or skin grafts with 6-aryl pyrimidine compounds |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
IL85746A (en) | 1988-03-15 | 1994-05-30 | Yeda Res & Dev | Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases |
FI891226A (fi) | 1988-04-28 | 1989-10-29 | Univ Leland Stanford Junior | Reseptordeterminanter i anti-t-celler foer behandling av autoimmunsjukdom. |
JP2681061B2 (ja) | 1988-06-08 | 1997-11-19 | ロンドン・ダイアグノスティック・インコーポレーテッド | 検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ |
WO1990008187A1 (en) | 1989-01-19 | 1990-07-26 | Dana Farber Cancer Institute | Soluble two domain cd2 protein |
JP3472297B2 (ja) | 1989-03-21 | 2003-12-02 | ザ イミューン レスポンス コーポレイション | 特定のt細胞集団の病原性応答により生じる疾患に対するワクチン接種および方法 |
CA2064077C (en) | 1989-07-19 | 2002-03-12 | Arthur A. Vandenbark | T cell receptor peptides as therapeutics for autoimmune and malignant disease |
US6251581B1 (en) | 1991-05-22 | 2001-06-26 | Dade Behring Marburg Gmbh | Assay method utilizing induced luminescence |
US5279607A (en) | 1991-05-30 | 1994-01-18 | The State University Of New York | Telemetry capsule and process |
US5314805A (en) | 1991-10-28 | 1994-05-24 | Molecular Probes, Inc. | Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM |
US5318557A (en) | 1992-07-13 | 1994-06-07 | Elan Medical Technologies Limited | Medication administering device |
DK1087013T3 (da) | 1992-08-21 | 2009-05-11 | Univ Bruxelles | Immunoglobuliner uden lette kæder |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
US5763602A (en) | 1996-10-01 | 1998-06-09 | Li; Ying-Syi | Methods of syntheses of phthalocyanine compounds |
US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
UA67760C2 (uk) | 1997-12-11 | 2004-07-15 | Міннесота Майнінг Енд Мануфакчурінг Компані | Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
WO1999042838A1 (en) | 1998-02-18 | 1999-08-26 | Dade Behring Inc. | Chemiluminescent compositions for use in detection of multiple analytes |
US6331530B1 (en) | 1999-07-13 | 2001-12-18 | The Trustees Of Columbia University In The City Of New York | Hydrophilic carrier for photosensitizers that cleaves when they catalyze the formation of singlet oxygen |
US6703248B1 (en) | 1999-12-15 | 2004-03-09 | Dade Behring Marburg Gmbh | Particles for diagnostic and therapeutic use |
GB9930000D0 (en) | 1999-12-21 | 2000-02-09 | Phaeton Research Ltd | An ingestible device |
US20030117491A1 (en) | 2001-07-26 | 2003-06-26 | Dov Avni | Apparatus and method for controlling illumination in an in-vivo imaging device |
WO2003076649A1 (en) | 2002-03-05 | 2003-09-18 | Aclara Biosciences, Inc. | Multiplex analysis using membrane-bound sensitizers |
US7797033B2 (en) | 2002-04-08 | 2010-09-14 | Smart Pill Corporation | Method of using, and determining location of, an ingestible capsule |
ATE482694T1 (de) | 2002-07-05 | 2010-10-15 | Temrel Ltd | Zusammensetzung zur kontrollierten wirkstoffabgabe |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US20040253304A1 (en) | 2003-01-29 | 2004-12-16 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
WO2005000101A2 (en) | 2003-06-12 | 2005-01-06 | University Of Utah Research Foundation | Apparatus, systems and methods for diagnosing carpal tunnel syndrome |
US7402398B2 (en) | 2003-07-17 | 2008-07-22 | Monogram Biosciences, Inc. | Measuring receptor homodimerization |
JP4445732B2 (ja) | 2003-08-29 | 2010-04-07 | オリンパス株式会社 | 被検体内導入装置および無線型被検体内情報取得システム |
US20050065441A1 (en) | 2003-08-29 | 2005-03-24 | Arkady Glukhovsky | System, apparatus and method for measurement of motion parameters of an in-vivo device |
JP2005074031A (ja) | 2003-09-01 | 2005-03-24 | Pentax Corp | カプセル内視鏡 |
KR20060092254A (ko) | 2003-09-23 | 2006-08-22 | 라이트 사이언시즈 코포레이션 | 표적화된 pdt 제제의 선택성을 증진시키는 표적 결합에의해 활성화된 일중항 산소 감광제 |
US8206285B2 (en) | 2003-12-31 | 2012-06-26 | Given Imaging Ltd. | Apparatus, system and method to indicate in-vivo device location |
EP1734933B1 (en) * | 2004-03-26 | 2010-05-26 | LEK Pharmaceuticals d.d. | Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423) |
US7970455B2 (en) * | 2004-05-20 | 2011-06-28 | Spectrum Dynamics Llc | Ingestible device platform for the colon |
DE602005023608D1 (de) | 2004-05-21 | 2010-10-28 | Given Imaging Ltd | Vorrichtung, system und verfahren zur in-vivo-probenentnahme |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
CN105153306B (zh) | 2005-06-07 | 2020-12-11 | 艾斯巴技术-诺华有限责任公司 | 抑制TNFα的稳定和可溶的抗体 |
US20070027362A1 (en) | 2005-07-27 | 2007-02-01 | Olympus Medical Systems Corp. | Infrared observation system |
US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
BRPI0615026A8 (pt) | 2005-08-19 | 2018-03-06 | Abbott Lab | imunoglobulina de domínio variável duplo e seus usos |
US8338416B2 (en) * | 2006-03-16 | 2012-12-25 | Pharmacylics, Inc. | Indole derivatives as inhibitors of histone deacetylase |
EP2063785A4 (en) | 2006-09-06 | 2011-08-31 | Innurvation Inc | SYSTEM AND METHOD FOR EXCHANGE OF ACOUSTIC INFORMATION INVOLVING A LOW-POWERFUL CAPABLE OF INTEGRATION |
RU2009120512A (ru) * | 2006-10-31 | 2010-12-10 | Конинклейке Филипс Электроникс Н.В. (Nl) | Конструкция глотаемого дозирующего устройства с множеством форсунок для выпуска лекарств в желудочно-кишечный тракт |
EP2125076B1 (en) * | 2007-02-26 | 2012-06-20 | Duocure, Inc. | Spray administration of compositions including active agents such as peptides to the gastrointestinal tract |
JP4932588B2 (ja) | 2007-05-08 | 2012-05-16 | オリンパス株式会社 | 画像処理装置および画像処理プログラム |
EP2725035A1 (en) | 2007-10-02 | 2014-04-30 | Avaxia Biologics, Inc. | Antibody therapy for use in the digestive tract |
US20100331827A1 (en) | 2008-02-18 | 2010-12-30 | Koninklijke Philips Electronics N.V. | Administration of drugs to a patient |
KR100931946B1 (ko) | 2009-06-10 | 2009-12-15 | 주식회사 인트로메딕 | 캡슐 내시경에 의해 촬영된 이미지 데이터를 저장하고 있는 서버로부터 관심있는 데이터를 우선하여 단말기에 수신하여 확인할 수 있도록 하는 서버-클라이언트 시스템의 이미지 데이터 전송 프로세싱 방법 |
WO2011004395A1 (en) | 2009-07-06 | 2011-01-13 | Intas Biopharmaceuticals Limited | Microemulsion formulation for biologicals |
US20120136209A1 (en) | 2009-08-05 | 2012-05-31 | Tel Hashomer Medical Research Infrastructure And Services, Ltd. | Methods and devices for providing information useful in the diagnosis of abnormalities of the gastrointestinal tract |
US9026192B2 (en) | 2009-11-24 | 2015-05-05 | Given Imaging Ltd | Device and method for in vivo imaging |
US20130129675A1 (en) * | 2009-12-04 | 2013-05-23 | Board Of Regents, The University Of Texas System | Interferon therapies in combination with blockade of stat3 activation |
EP2571573A4 (en) | 2010-03-17 | 2013-12-04 | Photopill Medical Ltd | PHOTOTHERAPY BY CAPSULE |
WO2012000970A1 (en) | 2010-07-01 | 2012-01-05 | Cellzome Limited | Triazolopyridines as tyk2 inhibitors |
BR112013011520A2 (pt) | 2010-11-19 | 2019-09-24 | Hoffmann La Roche | pirazolo piridinas e pirazolo piridinas e seu uso como inibidores de tyk2 |
US9527925B2 (en) * | 2011-04-01 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to VEGF and ANG2 |
EP2623017B1 (en) | 2011-04-01 | 2017-11-08 | Olympus Corporation | Receiving device and capsule endoscope system |
WO2012158648A1 (en) | 2011-05-13 | 2012-11-22 | Massachusetts Institute Of Technology | Method and apparatus for delivering a substance |
US8907081B2 (en) | 2011-05-27 | 2014-12-09 | Sharp Laboratories Of America, Inc. | Long wavelength absorbing porphyrin photosensitizers for dye-sensitized solar cells |
WO2013080050A2 (en) | 2011-11-30 | 2013-06-06 | Universitaetsklinikum Erlangen | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
EP2790564A4 (en) | 2011-12-15 | 2016-06-08 | Given Imaging Ltd | DEVICE, SYSTEM AND METHOD FOR IN VIVO DETECTION OF BLEEDINGS IN THE STOMACH DARM TRACT |
US9795330B2 (en) | 2011-12-15 | 2017-10-24 | Given Imaging Ltd. | Device, system and method for in-vivo detection of bleeding in the gastrointestinal tract |
WO2013113326A1 (en) | 2012-01-31 | 2013-08-08 | Curevac Gmbh | Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen |
FR2986432B1 (fr) | 2012-02-06 | 2014-03-14 | Univ Lille Ii Droit & Sante | Proteines 28kda gst provenant de schistosomes pour leur utilisation dans le traitement des maladies inflammatoires auto-immunes engendrant une reponse de type th1 et/ou th17 |
EP3725234A1 (en) | 2012-02-17 | 2020-10-21 | Progenity, Inc. | Ingestible medical device |
PL2634185T3 (pl) | 2012-03-02 | 2016-06-30 | Sareum Ltd | Inhibitory kinazy TYK2 |
CA2875990A1 (en) | 2012-05-24 | 2013-11-28 | Cellzome Limited | Heterocyclyl pyrimidine analogues as tyk2 inhibitors |
ES2867048T3 (es) * | 2012-06-15 | 2021-10-20 | Concert Pharmaceuticals Inc | Derivados deuterados de ruxolitinib |
TWI527811B (zh) * | 2013-05-09 | 2016-04-01 | 吉李德科學股份有限公司 | 作爲溴結構域抑制劑的苯並咪唑衍生物 |
KR20160013163A (ko) | 2013-05-24 | 2016-02-03 | 네스텍 소시에테아노님 | 과민성 대장 증후군 진단을 예측하기 위한 경로 특이적 검정법 |
US9324145B1 (en) | 2013-08-08 | 2016-04-26 | Given Imaging Ltd. | System and method for detection of transitions in an image stream of the gastrointestinal tract |
US20160235663A1 (en) | 2013-09-26 | 2016-08-18 | Medimetrics Personalized Drug Delivery, B.V. | Delivery capsule with threshold release |
EP3060234A1 (en) | 2013-10-24 | 2016-08-31 | AbbVie Inc. | Jak1 selective inhibitor and uses thereof |
WO2015099749A1 (en) | 2013-12-27 | 2015-07-02 | Capso Vision Inc. | Capsule camera device with multi-spectral light sources |
BR112016015140A2 (pt) | 2013-12-30 | 2018-01-23 | Epimab Biotherapeutics Inc. | imunoglobulina com fabs in-tandem e usos das mesmas |
WO2015112575A1 (en) | 2014-01-22 | 2015-07-30 | The Board Of Regents Of The University Of Nebraska | Gastrointestinal sensor implantation system |
US10281017B2 (en) | 2014-05-30 | 2019-05-07 | Schaeffler Technologies AG & Co. KG | Torque converter including spherical clutch |
CA2955666A1 (en) * | 2014-08-13 | 2016-02-18 | Cedars-Sinai Medical Center | Anti-methanogenic compositions and uses thereof |
WO2016049602A1 (en) | 2014-09-25 | 2016-03-31 | Progenity, Inc. | Electromechanical pill device with localization capabilities |
US9714288B2 (en) | 2014-09-30 | 2017-07-25 | The Regents Of The University Of California | Antisense compounds and uses thereof |
CN104473611B (zh) | 2015-01-19 | 2018-01-30 | 吉林大学 | 具有超声波定位功能的胶囊内窥镜系统 |
US10064544B2 (en) * | 2015-01-26 | 2018-09-04 | The Chinese University Of Hong Kong | Endoscopic capsule and endoscopic system |
TWI788655B (zh) | 2015-02-27 | 2023-01-01 | 美商林伯士拉克許米公司 | 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途 |
US10709773B2 (en) * | 2015-03-06 | 2020-07-14 | Synthetic Biologics, Inc. | Safe and effective beta-lactamase dosing for microbiome protection |
US10773063B2 (en) | 2015-05-31 | 2020-09-15 | Check-Cap Ltd | Drug delivery capsule |
JP2017012395A (ja) | 2015-06-30 | 2017-01-19 | 富士フイルム株式会社 | 内視鏡システム及び内視鏡システムの作動方法 |
US10588608B2 (en) | 2016-08-18 | 2020-03-17 | Progenity, Inc. | Sampling systems and related materials and methods |
IL265210B2 (en) | 2016-09-09 | 2023-03-01 | Jones Mitchell Lawrence | An edible electromechanical device for dispensing a dispensable substance |
WO2018048754A1 (en) | 2016-09-09 | 2018-03-15 | Mitchell Lawrence Jones | Systems and methods for extracting a sample from an ingestible device |
US20180206726A1 (en) | 2016-12-07 | 2018-07-26 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
WO2018111466A1 (en) | 2016-12-14 | 2018-06-21 | Mitchell Lawrence Jones | Ingestible device recovery system |
CA3046975A1 (en) | 2016-12-15 | 2018-06-21 | Progenity, Inc. | Ingestible device and associated methods |
WO2018183711A2 (en) | 2017-03-31 | 2018-10-04 | Progenity Inc. | Localization systems and methods for an ingestible device |
WO2023091991A1 (en) | 2021-11-17 | 2023-05-25 | H2 Clipper, Inc. | Improved system, method and apparatus for airship manufacture using robotics |
-
2017
- 2017-12-14 BR BR112019012062-9A patent/BR112019012062A2/pt not_active IP Right Cessation
- 2017-12-14 MX MX2019006821A patent/MX2019006821A/es unknown
- 2017-12-14 CN CN202310685573.1A patent/CN116869457A/zh active Pending
- 2017-12-14 AU AU2017378398A patent/AU2017378398B2/en active Active
- 2017-12-14 JP JP2019531761A patent/JP2020502126A/ja active Pending
- 2017-12-14 EP EP17826643.3A patent/EP3554485B9/en active Active
- 2017-12-14 US US16/468,158 patent/US11033490B2/en active Active
- 2017-12-14 CN CN201780077484.1A patent/CN110072519A/zh active Pending
- 2017-12-14 CA CA3045666A patent/CA3045666A1/en active Pending
- 2017-12-14 KR KR1020197019708A patent/KR20190097107A/ko not_active IP Right Cessation
- 2017-12-14 WO PCT/US2017/066492 patent/WO2018112245A1/en unknown
- 2017-12-14 EP EP22209435.1A patent/EP4190318A1/en active Pending
-
2021
- 2021-05-06 US US17/313,339 patent/US11857669B2/en active Active
-
2023
- 2023-01-04 JP JP2023000128A patent/JP2023052188A/ja active Pending
- 2023-03-03 AU AU2023201348A patent/AU2023201348A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3554485A1 (en) | 2019-10-23 |
KR20190097107A (ko) | 2019-08-20 |
BR112019012062A2 (pt) | 2019-11-12 |
JP2020502126A (ja) | 2020-01-23 |
US20220105026A1 (en) | 2022-04-07 |
CA3045666A1 (en) | 2018-06-21 |
WO2018112245A1 (en) | 2018-06-21 |
AU2023201348A1 (en) | 2023-04-06 |
US11033490B2 (en) | 2021-06-15 |
AU2017378398A1 (en) | 2019-06-13 |
EP3554485B9 (en) | 2023-09-27 |
EP4190318A1 (en) | 2023-06-07 |
JP2023052188A (ja) | 2023-04-11 |
AU2017378398B2 (en) | 2023-02-02 |
US11857669B2 (en) | 2024-01-02 |
CN116869457A (zh) | 2023-10-13 |
EP3554485B1 (en) | 2023-06-07 |
US20200197295A1 (en) | 2020-06-25 |
CN110072519A (zh) | 2019-07-30 |
EP3554485C0 (en) | 2023-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019006821A (es) | Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos. | |
MX2019006864A (es) | Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de factor de necrosis tumoral (tnf). | |
GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
IL279260A (en) | KDM1A inhibitors for the treatment of diseases | |
GB201804514D0 (en) | Treatment of pyroptosis | |
ZA202100528B (en) | Acid gas treatment | |
IL274541A (en) | A method for treating diseases of the digestive tract using Tradifitant | |
IL283948A (en) | Methods for treating depression | |
ZA201906213B (en) | Compounds and methods for the treatment of parasitic diseases | |
IL272937A (en) | Preparations and methods for the treatment of diseases involving fibrosis | |
IL287904A (en) | Combined treatment of arthritis | |
GB201804515D0 (en) | Treatment of necroptosis | |
GB202015959D0 (en) | Treatment of diseases involving NAD | |
ZA201903222B (en) | Compositions and methods for the treatment of gastrointestinal polyps | |
GB201805100D0 (en) | Treatment of sarcopenic diseases | |
SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
WO2015113041A3 (en) | Compositions and methods for treating autoimmune and inflammatory diseases | |
GB201811911D0 (en) | Treatment of disease | |
GB201811912D0 (en) | Treatment of disease | |
GB201810974D0 (en) | Treatment of disease | |
IL272124A (en) | Treatment of non-inflammatory lesions | |
GB201809835D0 (en) | Treatment of gastrointestinal disease | |
GB201803494D0 (en) | Treatment regime | |
GB201714014D0 (en) | Treatment of urinary tract disorders |